연구동향 분석

Updates on Prevention of Cardioembolic Strokes

Mehmet Akif Topcuoglu Liping Liu 김동억 M. Edip Gurol 2018년

논문상세정보
인용/피인용

' Updates on Prevention of Cardioembolic Strokes' 의 참고문헌

  • Warfarin and aspirin in patients with heart failure and sinus rhythm
    Homma S [2012]
  • Value of brain MRI in infective endocarditis: a narrative literature review
    Champey J [2016]
  • Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation
    Gage BF [2001]
  • Utility of brain magnetic resonance imaging in the surgical management of infective endocarditis
  • Updates on Prevention of Hemorrhagic and Lacunar Strokes
  • Transcranial Doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale
    Tobe J [2016]
  • Thrombophilia testing and venous thrombosis
    Connors JM [2017]
  • Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
  • The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Steffel J [2018]
  • Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
    Tawfik A [2016]
  • Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study
    Cooper HA [2009]
  • Self-monitoring and self-management of oral anticoagulation
    Heneghan CJ [2016]
  • Secondary stroke prevention in atrial fibrillation: new insights into an old problem
    Gurol ME [2018]
  • Rivaroxaban with or without aspirin in stable cardiovascular disease
  • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    Patel MR [2011]
  • Rivaroxaban for stroke prevention after embolic stroke of undetermined source
    Hart RG [2018]
  • Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) trials
  • Retrospective review of cerebral mycotic aneurysms in 26 patients: focus on treatment in strongly immunocompromised patients with a brief literature review
    Allen LM [2013]
  • Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis
    Murthy SB [2017]
  • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
    Lip GY [2010]
  • Recommendations for the use of mechanical circulatory support: ambulatory and community patient care. A scientific statement from the American Heart Association
    Cook JL [2017]
  • Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke: effect of lost-to-follow-up and withdrawal of consent
    Dellborg M [2016]
  • Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial
  • Proposed diagnostic criteria for intracranial infectious aneurysms
    Kannoth S [2008]
  • Prevention of bleeding in patients with atrial fibrillation undergoing PCI
    Gibson CM [2016]
  • Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation
    Reddy VY [2017]
  • Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism
    Martin F [2002]
  • Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial
    Reddy VY [2014]
  • Percutaneous closure of patent foramen ovale in cryptogenic embolism
    Meier B [2013]
  • Patent foramen ovale: a review of associated conditions and the impact of physiological size
    Kerut EK [2001]
  • Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke
  • Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke
    Mas JL [2017]
  • Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
    Aguilar MI [2007]
  • Nonpharmacological management of atrial fibrillation in patients at high intracranial hemorrhage risk
    Gurol ME [2018]
  • Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study
  • Meta-analysis comparing patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke
    Ando T [2018]
  • Meta-analysis : antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Hart RG [2007]
  • Long-term outcomes of patent foramen ovale closure or medical therapy after stroke
    Saver JL [2017]
  • Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population
    Ziegler PD [2017]
  • Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug
    Tzikas A [2016]
  • Intravenous thrombolysis is unsafe in stroke due to infective endocarditis
    Brownlee WJ [2014]
  • Intracranial microbial aneurysm (infectious aneurysm): current options for diagnosis and management
    Kannoth S [2009]
  • Intracranial infectious aneurysms: a comprehensive review
    Ducruet AF [2010]
  • Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association
    Baddour LM [2015]
  • Infective endocarditis
    Holland TL [2016]
  • Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study
    Cramer SC [2004]
  • Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction
    Kajermo U [2014]
  • Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts
    Hagen PT [1984]
  • In-office insertion of a miniaturized insertable cardiac monitor: results from the Reveal LINQ In-Office 2 randomized study
    Rogers JD [2017]
  • Imaging of cerebral aneurysms: a clinical perspective
    Yoon NK [2016]
  • Idarucizumab for dabigatran reversal: full cohort analysis
  • Heart disease and stroke statistics-2017 update: A report from the American Heart Association
    Benjamin EJ [2017]
  • Heart Failure as a Risk Factor for Stroke
  • Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010
  • Frequency and predictors of stroke after acute myocardial infarction: specific aspects of in-hospital and postdischarge events
    Hachet O [2014]
  • Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial
    Ailawadi G [2011]
  • Endovascular management of cerebral septic embolism: three recent cases and review of the literature
    Scharf EL [2017]
  • Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    Nielsen PB [2017]
  • Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study
    Homma S [2002]
  • Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study
    Duval X [2010]
  • Edoxaban versus warfarin in patients with atrial fibrillation
  • Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
    Cannon CP [2017]
  • Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study
    Di Biase L [2012]
  • Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage
  • Diagnosis of venous thromboembolism: 20 years of progress
    Wells PS [2018]
  • Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study
    Iung B [2013]
  • Dabigatran versus warfarin in patients with atrial fibrillation
    Connolly SJ [2009]
  • Current strategies to minimize the bleeding risk of warfarin
  • Cryptogenic stroke and underlying atrial fibrillation
    Sanna T [2014]
  • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
    Ruff CT [2014]
  • Closure or medical therapy for cryptogenic stroke with patent foramen ovale
    Furlan AJ [2012]
  • Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis
    Ntaios G [2018]
  • Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials
    Niu X [2018]
  • Cerebrovascular ischemic events in wind instrument players
    Evers S [2000]
  • Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis
    Okazaki S [2011]
  • Atrial fibrillation for the neurologist: preventing both ischemic and hemorrhagic strokes
    Gokcal E [2018]
  • Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
  • Apixaban versus warfarin in patients with atrial fibrillation
    Granger CB [2011]
  • Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
    Connolly SJ [2016]
  • Anatomic analysis of the left atrial appendage after closure with the LARIAT device
    Bartus K [2014]
  • An update on the prognosis of patients with atrial fibrillation
    McManus DD [2012]
  • Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study
    Singhal AB [2002]
  • A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score
    Singer DE [2013]
  • A fully magnetically levitated circulatory pump for advanced heart failure
    Mehra MR [2017]
  • 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
    Powers WJ [2018]
  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
    Kirchhof P [2016]
  • 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines
    Levine GN [2016]
  • 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)
    Habib G [2015]
  • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society
    January CT [2014]
  • "Economy class" stroke syndrome?
    Isayev Y [2002]